ProteoCell Biotechnologies was launched in 2003 to provide bioprocess solutions to small and emerging biotechnology companies with a lack of in-house bioprocess development and biopharmaceutical manufacturing expertise. From the outset, the vision of the founders was to assemble a platform able to offer the latest bioprocess resources and technologies in a rapidly evolving industry to the biopharmaceutical discovery sector, providing clients and partners with a cutting-edge operational and standardized manufacturing development environment and innovative science. But with this innovation, also came an unwavering commitment to quality built into the science from the outset—as well as conforming to GLP, GMP, and Quality Assurance above and beyond established industry standards. Also from the outset, the philosophy was to integrate cell line engineering, process engineering, and facility engineering as the core design elements for a complete, robust, and regulatory friendly bioprocess manufacturing platform.